India to Canada: Famotidine Export Trade Route

The India to Canada Famotidine corridor is one of India's established pharmaceutical export routes, with 69 shipments documented worth a combined $719.2K USD. The route is dominated by FINOSO PHARMA PRIVATE LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's famotidine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $10.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 19.4%, placing it at rank #18 among India's top famotidine export destinations globally.

On the import side, key buyers of Indian famotidine in Canada include JAMP PHARMA CORP, JAMP PHARMA CORPORATION, JAMP PHARMA CORP, and 8 others. JAMP PHARMA CORP is the single largest importer with 19 shipments valued at $228.8K USD.

India's famotidine exports to Canada are driven primarily by a handful of large-scale manufacturers. FINOSO PHARMA PRIVATE LIMITED with 31 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FINOSO PHARMA PRIVATE LIMITED, FINOSO PHARMA PRIVATE LIMITED , WINDLAS BIOTECH LIMITED — together account for 90% of total trade value on this route. The average shipment value of $10.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as jamp famotidine 20 mg tablets 100s din 02507749 and jamp famotidine 20 mg tablets (act. qty.47116 packs x100's), suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, JAMP PHARMA CORP is the largest importer with 19 shipments worth $228.8K USD — representing 32% of all famotidine imports from India on this route. A total of 11 buyers are active on this corridor.